Showing results (71-80 of 107) with videos related to
Sort By:
Pageof 11
The Journal of Dermatological Treatment|October 5, 2010
Improving clinical trial design in psoriasis: Perspectives from the global dermatology communityPeter van de Kerkhof, Jonathan Barker, Christopher E M Griffiths, et al.The Journal of Allergy and Clinical Immunology|May 7, 2026
HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactionsChuang-Wei Wang, Wei-Ti Chen, Chun-Bing Chen, et al.The Journal of Allergy and Clinical Immunology|August 14, 2020
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in AsiansChuang-Wei Wang, Wichittra Tassaneeyakul, Chun-Bing Chen, et al.The Journal of Allergy and Clinical Immunology|October 19, 2020
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based studySatveer K Mahil, Nick Dand, Kayleigh J Mason, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping studyEmma Vyvey, Rani Soenen, Hazel H Oon, et al.The Journal of Investigative Dermatology|August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort StudyNina Wilkinson, Teresa Tsakok, Nick Dand, et al.Science Translational Medicine|February 14, 2014
Integrative biology approach identifies cytokine targeting strategies for psoriasisGayathri K Perera, Chrysanthi Ainali, Ekaterina Semenova, et al.The New England Journal of Medicine|October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisMark Lebwohl, Bruce Strober, Alan Menter, et al.The Journal of Investigative Dermatology|February 21, 2025
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing DashboardCharlotte M Thomas, David Baudry, Zehra Arkir, et al.BMJ Open|August 21, 2025
Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocolDavid Gleeson, Sarah Chapman, Helen McAteer, et al.Pageof 11